Thomas O'Keefe, MD
FELLOW
Surgery
School of Medicine

Publications (19)

Top publication keywords:
Receptors, EstrogenReceptors, ProgesteroneBreastSentinel Lymph NodeMastectomyNeoplasm Recurrence, LocalCarcinoma, Ductal, BreastSEER ProgramCarcinoma, Intraductal, NoninfiltratingMastectomy, SegmentalBiomarkers, TumorCarcinoma, LobularNeoplasm, ResidualBreast NeoplasmsLymphadenopathy

• Modernizing Surgical Quality: A Novel Approach to Improving Detection of Surgical Site Infections in the Veteran Population.
  Surgical infections 2024 Perkins L, O'Keefe T, Ardill W, Potenza B
• Distance of Biopsy-Confirmed High-Risk Breast Lesion from Concurrently Identified Breast Malignancy Associated with Risk of Carcinoma at the High-Risk Lesion Site.
  Cancers 2024 Le J, O'Keefe TJ, Khan S, Grossi SM, Choi HY, Ojeda-Fournier H, Armani A, Wallace AM, Blair SL
• Duration of Endocrine Treatment for DCIS impacts second events: Insights from a large cohort of cases at two academic medical centers.
  Research square 2024 O'Keefe T, Yau C, Iaconetti E, Jeong E, Brabham C, Kim P, McGuire J, Griffin A, Wallace A, Esserman L, Harismendy O, Hirst G
• Reply to: "Is Choosing Wisely Wise for Lobular Carcinoma in Patients Over 70 Years of Age? A National Cancer Database Analysis of Sentinel Node Practice Patterns.
  Annals of surgical oncology 2023 Goldhaber N, O'Keefe T, Blair S
• Is Choosing Wisely Wise for Lobular Carcinoma in Patients Over 70 Years of Age? A National Cancer Database Analysis of Sentinel Node Practice Patterns.
  Annals of surgical oncology 2023 Goldhaber NH, O'Keefe T, Kang J, Douglas S, Blair SL

Show all (14 more) Hide

• Prognostic Significance of Residual Ductal Carcinoma In Situ After Complete Response of Invasive Breast Cancer to Neoadjuvant Therapy.
  JAMA surgery 2023 O'Keefe TJ, Wallace AM
• Bilateral mastectomy associated with higher breast cancer mortality among patients with estrogen receptor positive progesterone receptor negative localized breast cancer.
  Chinese clinical oncology 2023 O'Keefe TJ, Harismendy O, Wallace AM
• Accurate genome-wide genotyping from archival tissue to explore the contribution of common genetic variants to pre-cancer outcomes.
  Journal of translational medicine 2022 Nachmanson D, Pagadala M, Steward J, Cheung C, Bruce LK, Lee NQ, O'Keefe TJ, Lin GY, Hasteh F, Morris GP, Carter H, Harismendy O
• Efficacy and safety of neoadjuvant pertuzumab plus trastuzumab in combination with chemotherapy regimen in Chinese patients with HER2-positive early breast cancer: a real-world retrospective multi-center cohort study.
  Annals of translational medicine 2022 Zhou M, Wang S, Wan N, Yuan S, Hu X, Zhou W, Qing B, Liu M, Sun W, Fan P, Wang J, Cao H, Xu H, Dai B, Tang P, Qian L, Zhao X, Xiao J, Zhou H, Hu J, Ding L, Tripodi D, Zdenkowski N, O'Keefe TJ, Sanchez…
• Risk factors for breast cancer mortality after ductal carcinoma in situ diagnosis differ from those for invasive recurrence.
  Surgery 2022 O'Keefe TJ, Chau H, Harismendy O, Wallace AM
• Histopathological growth distribution of ductal carcinoma in situ: tumor size is not "one size fits all".
  Gland surgery 2022 O'Keefe TJ, Harismendy O, Wallace AM
• The breast pre-cancer atlas illustrates the molecular and micro-environmental diversity of ductal carcinoma in situ.
  NPJ breast cancer 2022 Nachmanson D, Officer A, Mori H, Gordon J, Evans MF, Steward J, Yao H, O'Keefe T, Hasteh F, Stein GS, Jepsen K, Weaver DL, Hirst GL, Sprague BL, Esserman LJ, Borowsky AD, Stein JL, Harismendy O
• Large and diffuse ductal carcinoma in situ: potentially lethal subtypes of "preinvasive" disease.
  International journal of clinical oncology 2021 O'Keefe TJ, Harismendy O, Wallace AM
• Archives of Breast Cancer
  Personalization of Ductal Carcinoma In-Situ Management: Large Databases and an Emerging Role for Global Data Sharing. 2021 O’Keefe, T., Harismendy, O., Esserman, L., Wallace, A.M.
• Mutational profiling of micro-dissected pre-malignant lesions from archived specimens.
  BMC medical genomics 2020 Nachmanson D, Steward J, Yao H, Officer A, Jeong E, O'Keefe TJ, Hasteh F, Jepsen K, Hirst GL, Esserman LJ, Borowsky AD, Harismendy O
• Ductal carcinoma in situ in patients younger than 30 years: differences in adjuvant endocrine therapy and outcomes.
  Breast cancer research and treatment 2020 Halasz SR, O'Keefe T, Wallace AM, Blair SL
• Surveillance, Epidemiology, and End Results program underestimates breast cancer-specific mortality after ductal carcinoma in situ diagnosis.
  Breast cancer research and treatment 2020 O'Keefe TJ, Wallace AM
• HER2-Overexpressing Ductal Carcinoma In Situ Associated with Increased Risk of Ipsilateral Invasive Recurrence, Receptor Discordance with Recurrence.
  Cancer prevention research (Philadelphia, Pa.) 2020 O'Keefe TJ, Blair SL, Hosseini A, Harismendy O, Wallace AM
• Classical and Quantum Gravity
  Characterization of the seismic environment at the Sanford Underground Laboratory, South Dakota. 2010 Harms J, Acernese F, Barone F, Bartos I, Beker M, Brand JFJ, Christensen N, Coughlin M, DeSalvo R, Dorsher S, Heise J, Kandhasamy S, Mandic V, Marka S, Muller G, Naticchioni L, O'Keefe TJ, Rabeling DS…